Loading chat...
GA HB196
Bill
Status
Engrossed
3/6/2023
Primary Sponsor
Alan Powell
Click for details
AI Summary
- Georgia Access to Medical Cannabis Commission becomes subject to the Administrative Procedure Act, open meetings, open records, and state purchasing laws, replacing prior broad confidentiality exemptions for commission documents
- Commissioner of Agriculture must study and report on medical cannabis regulation by December 1, 2023, with findings to guide future production license expansion
- Class 1 and Class 2 production licensees may establish retail dispensing outlets at their production facilities, and any dispensing location may sell products from any licensed producer; additional dispensing licenses are triggered at 75,000 registered patients (up from 25,000) and every 50,000 patients thereafter (up from 10,000)
- Appeals of commission final decisions are transferred from Fulton County Superior Court to the Georgia State-wide Business Court, which must conduct expedited hearings confined to the record
- Qualifying conditions for low THC oil treatment are expanded to include ulcerative colitis and myasthenia gravis, and each commissioner must file an annual financial disclosure statement with the Office of Inspector General by July 1
Legislative Description
Georgia Access to Medical Cannabis Commission; subject to Administrative Procedure Act and laws governing open meetings and records; provide
Last Action
Senate Conference Committee Appointed 13th, 11th, 50th
3/7/2024
Committee Referrals
Regulated Industries and Utilities3/7/2023
Judiciary - Non-Civil2/2/2023
Full Bill Text
No bill text available